CLINICAL_TRIALS
trial_result
· 2016-03-08
Clinical Trial Update: Duration of Benefit for OnabotulinumtoxinA in Treatment of Chronic Migraine [Phase 4]
Summary
Phase 4 clinical trial update examining the duration of benefit of onabotulinumtoxinA for chronic migraine, with results posted in 2016.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Cady, Roger, M.D. | Conditions: Chronic Migraine | Phase 4 | Status: COMPLETED | Results posted: 2016-03-08